Nebraska Legislature Must Address Tobacco Crisis
Action Needed to Reduce the Burden of Cancer on Nebraskans
Washington, D.C.— Today the Senate voted to confirm Robert Califf as the next commissioner of the Food and Drug Administration (FDA).
A statement from Karen E. Knudsen, CEO of American Cancer Society American Cancer Society Cancer Action Network (ACS CAN) and Lisa Lacasse, president of ACS CAN follows:
“From reviewing and approving innovative therapies, to being given the mandate to regulate the entire tobacco industry, the work of the FDA plays a critical role in the fight against cancer. Given the complex and far-reaching work of the agency on cancer patients and families, a confirmed commissioner is vital to the agency’s work. We look forward to working with Dr. Califf at FDA to:
“On behalf of families affected by cancer, ACS CAN urges Dr. Califf and FDA to press forward on these critical issues that have impact on a disease that is expected to kill more than 609,000 Americans this year alone. Advancing cancer science into implementation is critical to improving the lives of cancer patients and their families.”
###